Jump to content

Tymazoline

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Lennart97 (talk | contribs) at 14:04, 12 July 2021 (Disambiguating links to Solution (link changed to Solution (chemistry)) using DisamAssist.). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Tymazoline
Clinical data
Trade namesThymazen
AHFS/Drugs.comInternational Drug Names
Routes of
administration
Topical (nasal solution)
ATC code
Identifiers
  • 2-[(5-methyl-2-propan-2-ylphenoxy)methyl]-4,5-dihydro-1H-imidazole
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC14H20N2O
Molar mass232.327 g·mol−1
3D model (JSmol)
  • Cc1ccc(c2c1cccc2OCC3=NCCN3)C(C)C
  • InChI=1S/C14H20N2O/c1-10(2)12-5-4-11(3)8-13(12)17-9-14-15-6-7-16-14/h4-5,8,10H,6-7,9H2,1-3H3,(H,15,16) checkY
  • Key:QRORCRWSRPKEHR-UHFFFAOYSA-N checkY
 ☒NcheckY (what is this?)  (verify)

Tymazoline (trade name Thymazen in Poland) is a nasal decongestant that can be used to treat rhinitis. It acts as an antihistaminic and sympathomimetic, reducing swelling, inflammation and mucosal secretions.[1][2]

References